HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukihiro Nakai Selected Research

verlukast

1/2021Increased [18F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukihiro Nakai Research Topics

Disease

2Neoplasms (Cancer)
03/2021 - 01/2021
1Hypoxia (Hypoxemia)
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021

Drug/Important Bio-Agent (IBA)

1NitroimidazolesIBA
03/2021
1Lapatinib (GW572016)FDA Link
01/2021
1fluoromisonidazoleIBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2021
1verlukastIBA
01/2021
1multidrug resistance-associated protein 1IBA
01/2021

Therapy/Procedure

1Intravenous Administration
03/2021
1Aftercare (After-Treatment)
01/2021